DE602004031116D1 - Von hla-klasse-ii-molekülen präsentierte ssx-2-peptide - Google Patents
Von hla-klasse-ii-molekülen präsentierte ssx-2-peptideInfo
- Publication number
- DE602004031116D1 DE602004031116D1 DE602004031116T DE602004031116T DE602004031116D1 DE 602004031116 D1 DE602004031116 D1 DE 602004031116D1 DE 602004031116 T DE602004031116 T DE 602004031116T DE 602004031116 T DE602004031116 T DE 602004031116T DE 602004031116 D1 DE602004031116 D1 DE 602004031116D1
- Authority
- DE
- Germany
- Prior art keywords
- peptides
- ssx
- hla class
- molecules presented
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48925703P | 2003-07-22 | 2003-07-22 | |
| PCT/US2004/023544 WO2005010190A1 (en) | 2003-07-22 | 2004-07-21 | Ssx-2 peptides presented by hla class ii molucules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004031116D1 true DE602004031116D1 (de) | 2011-03-03 |
Family
ID=34102841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004031116T Expired - Lifetime DE602004031116D1 (de) | 2003-07-22 | 2004-07-21 | Von hla-klasse-ii-molekülen präsentierte ssx-2-peptide |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7910696B2 (de) |
| EP (1) | EP1644501B1 (de) |
| AT (1) | ATE496129T1 (de) |
| DE (1) | DE602004031116D1 (de) |
| WO (1) | WO2005010190A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080033271A (ko) * | 2005-06-17 | 2008-04-16 | 맨카인드 코포레이션 | 암종을 위한 다가 동반이행 및 증폭형 면역치료제 |
| WO2009076541A1 (en) * | 2007-12-11 | 2009-06-18 | Toray Plastics (America), Inc. | Process to produce biaxially oriented polylactic acid film at high transverse orientation rates |
| US8846872B2 (en) * | 2009-11-18 | 2014-09-30 | Mannkind Corporation | Monoclonal antibodies and diagnostic uses thereof |
| ES2876176T3 (es) * | 2010-09-21 | 2021-11-12 | The Us Secretary Department Of Health And Human Services Office Of Technology Transfer National Inst | Receptores de células T anti-SSX-2 y materiales relacionados y métodos de uso |
| CN105293806B (zh) * | 2015-11-13 | 2017-11-21 | 中蓝连海设计研究院 | 一种t酸离析母液废水的综合治理方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9414580D0 (en) * | 1994-07-19 | 1994-09-07 | Cancer Res Campaign Tech | Materials and methods relating to the diagnosis of synovial sarcomas |
| US5840839A (en) * | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| US6548064B1 (en) * | 1997-05-05 | 2003-04-15 | Ludwig Institute For Cancer Research | Isolated peptides consisting of amino acid sequences found in SSX or NY-ESO-1 molecules, which bind to HLA molecules |
| US6287756B1 (en) * | 1997-05-05 | 2001-09-11 | Ludwig Institute For Cancer Research | Methods for determining presence of cancer in a sample by determining expression of an SSX gene |
| US6291430B1 (en) | 1997-09-12 | 2001-09-18 | Ludwig Institute For Cancer Research | Mage-3 peptides presented by HLA class II molecules |
| US6140050A (en) * | 1998-06-26 | 2000-10-31 | Ludwig Institute For Cancer Research | Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith |
| US6800730B1 (en) | 1998-10-02 | 2004-10-05 | Ludwig Institute For Cancer Research | Isolated peptides which bind to MHC class II molecules, and uses thereof |
| WO2001082963A2 (en) | 2000-04-28 | 2001-11-08 | Ctl Immunotherapies Corp. | Method of identifying and producing antigen peptides and use thereof as vaccines |
| WO2003008537A2 (en) | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
-
2004
- 2004-07-21 US US10/565,315 patent/US7910696B2/en not_active Expired - Fee Related
- 2004-07-21 EP EP04778867A patent/EP1644501B1/de not_active Expired - Lifetime
- 2004-07-21 DE DE602004031116T patent/DE602004031116D1/de not_active Expired - Lifetime
- 2004-07-21 AT AT04778867T patent/ATE496129T1/de active
- 2004-07-21 WO PCT/US2004/023544 patent/WO2005010190A1/en active Application Filing
-
2011
- 2011-02-16 US US13/028,953 patent/US9200047B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE496129T1 (de) | 2011-02-15 |
| WO2005010190A1 (en) | 2005-02-03 |
| EP1644501A1 (de) | 2006-04-12 |
| EP1644501B1 (de) | 2011-01-19 |
| US20060189001A1 (en) | 2006-08-24 |
| US20110144186A1 (en) | 2011-06-16 |
| US9200047B2 (en) | 2015-12-01 |
| US7910696B2 (en) | 2011-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002095051A3 (en) | Mage-a3 peptides presented by hla class ii molecules | |
| ZA988124B (en) | Mage-3 peptides presented by HLA class II molecules | |
| ATE427354T1 (de) | Mage-a3 polypeptide die durch hla-klasse ii molekule prasentiert werden | |
| CY1122250T1 (el) | Αντισωματα που κατευθυνονται εναντι her-3 και χρησεις αυτων | |
| CY1117786T1 (el) | Διαφορικα εκφραζομενα σε ογκους γονιδιακα προϊοντα και χρηση αυτων | |
| PH12019500122A1 (en) | Bispecific antibody-like binding proteins specifically binding to cd3 and cd123 | |
| ATE504602T1 (de) | Für humane matriptase spezifische bindungsproteine | |
| ATE441711T1 (de) | Peptide fähig die dimerisierung von c-jun zu inhibieren | |
| ATE519115T1 (de) | Verfahren für die identifizierung von allo- antigenen und ihre verwendung für krebstherapie und transplantation | |
| ATE488586T1 (de) | In vitro peptid-expressionsbank | |
| WO2004113500A3 (en) | B7s1: an immune modulator | |
| MX2023004020A (es) | Anticuerpos anti-ngf y métodos para su uso. | |
| MX2021010837A (es) | Receptores en linfocitos t de la proteina 1 de tumor de wilms (wt1) de alta avidez. | |
| RS20050577A (en) | Compositions and methods for treating cancer using igsf9 and liv-1 | |
| ATE496129T1 (de) | Von hla-klasse-ii-molekülen präsentierte ssx-2- peptide | |
| MXPA05006034A (es) | Proteina de duplicacion. | |
| IL207012A0 (en) | Diagnosis and therapy of cancer using sgp28-related molecules | |
| WO2005079490A3 (en) | Methods of therapy and diagnosis using targeting of cells that express steap2 polypeptides | |
| GB0324656D0 (en) | A protein involved in ovarian cancer | |
| WO2003020887A3 (en) | Gene identification | |
| DE602005021159D1 (de) | Bakteriophagen- und prophagen-proteine in der krebsgentherapie | |
| WO2004078918A3 (en) | Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides | |
| WO2003087408A3 (en) | Schizophrenia associated genes | |
| WO2005060667A3 (en) | Nucleic acid and amino acid sequences involved in pain | |
| TR201909281T4 (tr) | HER-3'e yönelik antikorlar ve bunların kullanımı. |